Peptide
Cerebroprotein Hydrolysate
SaveA mixture of low-molecular-weight neuropeptides and amino acids derived from porcine brain, similar to Cerebrolysin, used in some countries for neurological conditions.
Quick verdict
Similar concept to Cerebrolysin with overlapping but distinct formulations. Evidence base is smaller and primarily from Asian clinical studies.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Multiple small trials from China and India for traumatic brain injury and stroke. Methodological quality is generally low.
Benefits
- Some clinical trial data for traumatic brain injury
- Used clinically in several Asian countries
Dosage notes
Clinical use typically 10–30 mL IV daily. Requires clinical administration.
Side effects
- Injection-site reactions
- Headache
- Nausea
- Allergic reactions possible
Who should be cautious
Animal-derived biological product. Not approved in Western countries. Quality varies by manufacturer.
What this page cannot tell you
Smaller evidence base than Cerebrolysin with higher heterogeneity across formulations.
Leaderboard scores
- Memory30
- Recovery25
Write a review
Sign in to write a review.